Skip to content

Clinical trials

Phase 3 Urinary Bladder Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20052
20071
20092
20101
20131
20152
20162
20183
20193
20202
20212
20232
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting8
Unknown status5
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca3
Bristol-Myers Squibb2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
Pfizer2
University Hospital Birmingham2
Astellas Pharma Global Development, Inc.1
Bioniche Life Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms31
Carcinoma, Transitional Cell7
Urethral Neoplasms2
Urologic Neoplasms2
Carcinoma1
Carcinoma in Situ1
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Endometrial Neoplasms1
Mycobacterium Infections1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.